Discover how with the proper understanding of a site’s barriers, early engagement, and prioritizing effective training, site acceptance of ePRO can be improved.

Learn how CROs can leverage eClinical technology to more effectively differentiate themselves in the crowded marketplace and provide sponsors with better clinical trial support.

Recently, early-phase protocols have been collecting patient-reported outcomes (PROs) not only to get regulatory approval but to demonstrate value to public and private payers.

Discover how ePRO automatically incorporates eCOA data into a study, improving the depth, timeliness, and accuracy of patient-reported outcomes data in the following ways.

In this blog, explore how the approach to PROs needs to be reconsidered, given increasing regulations and trial scrutiny, the clinical need for patient-reported outcomes, and the ability to drive costs down and move off paper.

In this article, focus on the adoption of new clinical trial technology and explore how sponsors can support sites as they select and implement technologies.

The benefits of eConsent are multi-faceted. In this blog post, explore these advantages as they relate to participants, sites and sponsors/CROs.

When participant retention is not addressed, learn how studies need to recruit additional participants and extend trial timelines, leading ultimately to budget overruns. 

eConsent can have a positive impact on participant retention, but learn why that is only part of the challenge of meeting participant needs in a clinical trial.

Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.

Find out why one leading biotechnology company keeps choosing this eClinical technologies and services provider for EDC assistance.

Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.

Learn how a therapeutic oncology company was able to take advantage of an EDC system, establish a ePRO assessments collections platform, and receive guidance on data collection devices.

After experiencing paper processing issues, discover how a company transitioned to digital data collection by using Electronic Data Capture (EDC) and Electronic Patient Reported Outcomes (ePRO) solutions.

By using Medrio’s EDC platform, learn how Atlantic Research Group was able to achieve the flexibility needed to span multiple therapeutic areas and eliminate redundancy in documentation.

Electronic data capture (EDC) is straightforward, in theory. However, not every EDC is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.

What makes a clinical trials software provider a good fit? How do you make the decision to use a particular electronic data capture (EDC) system or electronic patient reported outcome (ePRO) solution? Learn how the answers are different for every sponsor and contract research organization (CRO).

Find out how the Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy an eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an endpoint for patients.

In a proof-of-concept for a decentralized hybrid study, explore how Electronic Patient-Reported Outcomes (ePRO) technology was used to assess the results of varying digital therapies and the feasibility of conducting a largely virtual clinical study in a fibromyalgia population.

Delve into how the TargetCancer Foundation implemented a remote consent function in their TCF-001 TRACK study with an objective to determine if rare tumors can benefit from matched molecular therapy.

Sciformix, an SPO (Scientific Process Organization) serving a diverse variety of clinical trials across all phases, has built substantial experience in Medrio in a short span of time. Find out how Medrio helped Sciformix reduce the cost and timeline of the study.

As clinical trials grow in complexity, discover how adopting adaptive, unified RTSM technology can help to reduce costs and maintain accurate, real-time study data.

Learn why an RTSM solution should be adaptive and flexible, and should help you uncover the best ways to handle protocol amendments.

In this article, explore how a full-service Randomization and Trial Supply Management (RTSM) solution, the next evolution of technologies like Interactive Response System (IRT),  can maximize efficiencies for study managers and their teams.

In this webinar, Medrio experts explore the fast-changing landscape of clinical trials today, and discuss new approaches to gain the agility needed to overcome global- and industry-level trial supply management challenges.

Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.

Learn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences. 

Explore the impact of the pandemic on trial operations and what the future of RTSM technology looks like with Medrio’s internal RTSM-expert, Ian Davison. 

Discover the ways in which a patient-centric approach can remove controllable barriers from the clinical trial process and strengthen patient engagement.

Reducing the number of vendors you interact with allows you to not only achieve higher quality data, you can also spend more time focusing on what matters- the patients. Our fully integrated RTSM and EDC allows you to spend more time focused on your data and less on outside programmers and vendors. In this episode we will explore the value of a combined solution and what you can expect in return.